<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362550">
  <stage>Registered</stage>
  <submitdate>27/05/2012</submitdate>
  <approvaldate>30/05/2012</approvaldate>
  <actrnumber>ACTRN12612000581864</actrnumber>
  <trial_identification>
    <studytitle>Comparative evaluation of isobaric ropivacaine (0.75%) with the adjuvants - clonidine and dexmedetomidine administered intrathecally in adult patients undergoing infra-umbilical surgeries</studytitle>
    <scientifictitle>Comparative evaluation of isobaric ropivacaine (0.75%) with the adjuvants - clonidine and dexmedetomidine administered intrathecally in adult patients undergoing infra-umbilical surgeries</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>intrathecal drugs</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>In this randomized double blind prospective clinical study we plan to evaluate the efficacy of adding  Clonidine (30mcg), Dexmedetomidine (5mcg) or isotonic saline to 0.75% isobaric Ropivacaine for administration of subarachnoid lumbar block in infra-umbilical surgical procedures with regard to characteristics of sensory and motor block and observation of any side effects. Each of these treatments will be given on just one occasion Thereare three groups.  
GROUP RS (Ropivacaine + Isotonic Saline) is the control group
They will be administered 3.0ml of 0.75% isobaric Ropivacaine + 0.2ml of Isotonic Saline (total volume of injectate 3.2ml) 
GROUP RC (Ropivacaine + Clonidine)
They will be administered 3.0ml of 0.75% isobaric Ropivacaine + 30mcg of Clonidine (0.2ml Inj. Clonidine; total volume of injectate 3.2ml)
GROUP RD (Ropivacaine + Dexmedetomidine)
They will be administered 3.0ml of 0.75% isobaric Ropivacaine + 5mcg of Dexmedetomidine (0.05ml of Dexmedetomidine diluted to 0.2ml in isotonic saline; total volume of injectate 3.2ml)</interventions>
    <comparator>1.	GROUP RS (Ropivacaine + Isotonic Saline) is the control group</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Duration of sensory block - it will be assessed clinically</outcome>
      <timepoint>Time to regression of sensory block to L1 dermatomal level</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Total duration of analgesia -- it will be assessed clinically</outcome>
      <timepoint>time between the injection and first request for analgesia</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Total duration of motor block - clinical assessment</outcome>
      <timepoint>time  from initial onset until complete recovery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to onset of sensory block to T10 and T8 dermatomal levels</outcome>
      <timepoint>time between injection and no sensation to prick at T10 and T8 levels</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients scheduled to undergo elective infra-umbilical surgery
ASA grades 1 and 2
height : 150 to 180 cms
Duration of surgery not exceeding 2 1/2  hours</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patient refusal
ASA grades 3 and 4
Contraindications to spinal anaesthesia (absolute and relative)
Patients with the following cardiovascular disorders:
Heart rate &lt; 55 beats/min
Patients on antihypertensive drug therapy
Those on heparin therapy, aspirin and other anti-platelet drug therapy
Hepatic and renal disorders
Obesity
pregnancy
Psychosis, dementia and other co-operation disorders
Peripheral neuropathy
Demyelinating central nervous system disorders
Disorders of spine eg. scoliosis
Chronic analgesic usage
Known hypersensitivity to drugs</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by computer</concealment>
    <sequence>randomization table created by a computer software (i.e. computerised sequence generation)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/04/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>90</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>India</country>
      <state>delhi</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>safdarjung hospital</primarysponsorname>
    <primarysponsoraddress>epartment of anaesthesia
safdarjung hospital,
new delhi-110029</primarysponsoraddress>
    <primarysponsorcountry>India</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>safdarjung hospital</fundingname>
      <fundingaddress>department of anaesthesia
safdarjung hospital,
new delhi -110029</fundingaddress>
      <fundingcountry>India</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>dr kapil gupta</sponsorname>
      <sponsoraddress>Assistant Professor, Department of Anaesthesia and Critical care,
V.M.M.C &amp; Safdarjung Hospital, New Delhi-110029, INDIA</sponsoraddress>
      <sponsorcountry>India</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In this randomized double blind prospective clinical study we plan to evaluate the efficacy of adding  Clonidine (30mcg), Dexmedetomidine (5mcg) or isotonic saline to 0.75% isobaric Ropivacaine for administration of subarachnoid lumbar block in infra-umbilical surgical procedures with regard to characteristics of sensory and motor block and observation of any side effects.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>safdarjung hospital ethics committee</ethicname>
      <ethicaddress>safdarjung hospital,
new delhi -110029</ethicaddress>
      <ethicapprovaldate>1/10/2011</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>India</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>dr kapil gupta</name>
      <address>Dr Kapil Gupta,
Assistant Professor, Department of Anaesthesia and Critical care,
V.M.M.C &amp; Safdarjung Hospital, New Delhi-110029, INDIA</address>
      <phone>919811859019</phone>
      <fax>91-11-45626460</fax>
      <email>kapilgupta75@indiatimes.com</email>
      <country>India</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>dr kapil gupta</name>
      <address>Dr Kapil Gupta,
Assistant Professor, Department of Anaesthesia and Critical care,
V.M.M.C &amp; Safdarjung Hospital, New Delhi-110029, INDIA</address>
      <phone>919811859019</phone>
      <fax>91-11-45626460</fax>
      <email>kapilgupta75@indiatimes.com</email>
      <country>India</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>